Their study demonstrated that PARP enzymes, which are highly expressed in T-ALL patients, participate in establishing H3K4me3 marks at the TET1 promoter and that PARP1 interacts with the TET1 protein. The gene discussed is PARP1; the disease is acute lymphoblastic leukemia.